ADRs Close Lower; Scinai Immunotherapeutics Ltd. Declines 37%

Dow Jones
18 hours ago

This article was automatically generated by Dow Jones using technology from Automated Insights.

International stocks trading in New York closed lower on Tuesday, as the S&P/BNY Mellon index of American depositary receipts dropped 0.6% to 270.80.

The European index dropped 0.3% to 240.01. The Asian index declined 1.0% to 359.18. The Latin American index increased 0.3% to 281.90, while the emerging-markets index declined 0.8% to 591.10.

Scinai Immunotherapeutics Ltd., based in Israel, posted the largest decline, plummeting 37% to $1.54, followed by shares of Australia's Radiopharm Theranostics Ltd., which plummeted 24% to $1.52. Shares of Hong Kong-based Studio City International Holdings Ltd. plunged 17% to $1.40.

Macau's CL Workshop Group Ltd. was the biggest leader during the session, rocketing 44% to $1.74, and China-based Jinxin Technology Holding Co. rocketed 27% to $2.28. Biodexa Pharmaceuticals PLC, which is based in United Kingdom, rounded out the top three leaders on Tuesday, with shares jumping 19% to $1.33.

Data source: Dow Jones Market Data, FactSet

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10